EUVIMEDEUVIMED entdecken
Crossref

Correlates of MAPK/Nrf2/STAT‐3 Pathway Protein Expression With Morin Treatment in Helicobacter pylori ‐Infected Gastric Epithelial Cells‐1 Cells: An Exploratory In Vitro Study

Yanping Zhang iD

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Yanping Zhang. Beteiligte Einrichtung: Department of Gastroenterology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shan…. Hauptthemen laut MEDLINE: Flavonoids, NF-E2-Related Factor 2, Helicobacter pylori, STAT3 Transcription Factor. Die Arbeit nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori infection is a major risk factor for gastric cancer (GC), but the molecular mechanisms remain incompletely understood. This exploratory in vitro study investigated whether treatment with the flavonoid morin correlates with altered expression of MAPK/Nrf2/STAT‐3 pathway proteins in H. pylori ‐infected human gastric epithelial cells (GES‐1). GES‐1 cells were infected with H. pylori (ATCC 49503, MOI 100:1) and treated with 40 µM morin for 24 h. Outcomes included cell viability (MTT assay), ROS production (DCFH‐DA), oxidative DNA damage (comet assay), glutathione and malondialdehyde levels (biochemical assays), protein expression (Western blot), and gene expression (RT‐PCR). Molecular docking predicted binding affinity between morin and pathway proteins. This study used n = 3 biological replicates per group and a lenient false discovery rate threshold ( Q = 0.25) appropriate for hypothesis generation; findings require independent replication. In this exploratory study, morin treatment (40 µM) was associated with: Higher MTT‐detectable viability in H. pylori ‐infected cultures compared to infected untreated controls (85% vs. 45%; q = 0.042) Lower intracellular ROS levels ( q = 0.021) and reduced oxidative DNA damage ( q = 0.018) compared to infected untreated controls Higher GSH and lower MDA levels compared to infected untreated controls Lower phosphorylation levels of MAPK family members (ERK, JNK, p38), PI3K/AKT, and STAT3/EGFR proteins compared to infected untreated controls Higher total Nrf2 protein expression and upregulation of HMOX1 and NQO1 mRNA compared to infected untreated controls Molecular docking predicted binding between morin and MAPK, STAT3, and NRF2 pathway proteins, but these computational findings require experimental validation. These correlative findings are consistent with the hypothesis that morin treatment engages MAPK/Nrf2/STAT‐3 pathways in H. pylori ‐infected GES‐1 cells. However, this study does not establish causality, Nrf2 activation (nuclear translocation not demonstrated), or therapeutic efficacy (no positive controls). The observed associations should be interpreted as hypothesis‐generating and require independent replication, mechanistic validation (including Nrf2 loss‐of‐function experiments), and comparative studies with standard agents before any translational inference. Under the specific in vitro conditions tested (GES‐1 cells, H. pylori ATCC 49503, 40 µM morin, 24‐h exposure, n = 3 biological replicates), morin treatment was associated with lower ROS levels, reduced MAPK/STAT3 phosphorylation, and higher Nrf2 protein expression compared to infected untreated controls. These correlative findings are hypothesis‐generating and do not establish therapeutic potential, safety, efficacy, or clinical relevance. Independent replication, comprehensive toxicological characterization (including normal cell lines and in vivo models), direct comparison with standard agents (clarithromycin, sulforaphane), and mechanistic validation (including Nrf2 loss‐of‐function experiments) are required before any consideration of morin for further development. This study provides no evidence to support morin as a therapeutic, adjuvant, or alternative agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsNF-E2-Related Factor 2Helicobacter pyloriSTAT3 Transcription FactorEpithelial CellsHelicobacter InfectionsSignal TransductionGastric MucosaFlavonesHumansMolecular Docking SimulationCell Line

Stichwörter der Autor:innen

H. pyloriMAPK signalingNrf2STAT3gastric cancerin vitro mechanistic studymorinpreliminary observation (no therapeutic claim)

Substanzen

FlavonoidsFlavonesmorinNF-E2-Related Factor 2STAT3 Transcription FactorNFE2L2 protein, humanSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
  • Faculty of Graduate Studies, Shanxi Medical University, Taiyuan, Shanxi, China.

ORCID-Profile: Yanping Zhang

Zitieren

APA

Zhang, Y. (2026). Correlates of MAPK/Nrf2/STAT‐3 Pathway Protein Expression With Morin Treatment in Helicobacter pylori ‐Infected Gastric Epithelial Cells‐1 Cells: An Exploratory In Vitro Study. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70935

Vancouver

Zhang Y. Correlates of MAPK/Nrf2/STAT‐3 Pathway Protein Expression With Morin Treatment in Helicobacter pylori ‐Infected Gastric Epithelial Cells‐1 Cells: An Exploratory In Vitro Study. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70935

BibTeX
@article{Zhang2026,
  author = {Zhang, Yanping},
  title = {Correlates of MAPK/Nrf2/STAT‐3 Pathway Protein Expression With Morin Treatment in Helicobacter pylori ‐Infected Gastric Epithelial Cells‐1 Cells: An Exploratory In Vitro Study},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70935}
}
Kostenlos starten →